Journal
AIDS
Volume 22, Issue 18, Pages 2461-2469Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0b013e328314b5f1
Keywords
AIDS; AIDS presenters; opportunistic infections; prognosis
Categories
Funding
- Istituto Superiore di Sanita [40G.43]
- Fundacicon, Maximo Soriano Jimenez (Barcelona, Spain) [30G.3]
- Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Invesngacion Sanitaria (FIS)
- Instituto de Salud Carlos III, Madrid (Spain) (Manzardo, Miro) [ISCIII-RETIC PD06/006]
- Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
- Conselleria de Salut de la Generalitat de Catalunya, Barcelona (Spain)
Ask authors/readers for more resources
Objective: Many patients infected with HIV still present with an AIDS diagnosis. The aim of this study was to evaluate the virological, immunological and clinical outcomes of HAART in these patients. Design: The present study was a multi-cohort study. All patients with an AIDS diagnosis between 30 days before and 14 days after HIV diagnosis, recruited between 1997 and 2004 from eight hospital cohorts, were evaluated. Results: A total of 760 patients were included [268 (35.3%) had pneumnocystis and 168 (22.1%) tuberculosis]. Six hundred and twenty-four patients (82.1%) started HAART a median of 31 days after HIV diagnosis. One hundred and fifty-three patients started a nonnucleoside transcriptase inhibitor-based regimen (20.1%), 409 a protease inhibitor-based regimen (53.8%) and 62 other regimens (8.2%). In adjusted analyses, HAART was started sooner in more recent years, in patients with lower CD4 cell count and in those with Kaposi's sarcoma, whereas it was started later in those with tuberculosis. Five hundred and five patients (89%) attained a viral load of less than 500 copies/ml. The factors associated with a better virological response were later calendar year, lower initial viral load and cytomegalovirus disease. Virological rebound was more common in those receiving nucleoside reverse transcriptase inhibitor-based regimens, in those with tuberculosis and in earlier calendar years. One hundred and twenty-five (16%) patients died; 61 had received HAART (48.6%). Mortality was more likely in those who were older, those with a higher viral load at diagnosis, those with nonsexual HIV risks and those with lower CD4 cell count and haemoglobin levels over follow-up. Conclusion: Virological suppression was achieved in most AIDS patients, though mortality remains high in these individuals. (C) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available